Emcure Pharmaceuticals develops and commercializes a range of formulations including biotechnology products across different therapeutic segments

Emcure sells products in 70+ countries including India, Europe, Canada, Russia, and Brazil. In the domestic market, it has a leading position in gynecology, cardiology, pain and analgesics, HIV, anti-infectives, nephrology, vitamins-minerals-nutrients products among others. The company offers products in both chronic and acute segments, while the chronic segment continues to remain its core focus.